Evidence-led comparison

Urolithin A vs CoQ10: renewal or energy transfer.

Read the verdict
50
US searches / month
13
Fatigue RCTs pooled
1,126
Participants pooled
Close view of cellular material representing mitochondrial energy transfer

The short answer

Different tools for different biological jobs.

CoQ10 is the more established choice for people specifically addressing low CoQ10 status, statin-associated concerns under clinical guidance, or fatigue, where meta-analyses report benefits across varied populations. Urolithin A is the more targeted choice for mitochondrial quality and muscle-aging priorities, particularly through mitophagy activation, selected human muscle outcomes, and consistent delivery independent of gut-microbiome conversion.

At a glance

Urolithin A and CoQ10, side by side.

The comparison is organized by biological role, evidence maturity, and the outcomes each ingredient is best positioned to support.

DimensionUrolithin ACoQ10Bottom line
Primary roleActivates mitochondrial quality control through mitophagyTransfers electrons in the respiratory chain and acts as an antioxidantRenewal versus energy transfer
Best-established useSelected mitochondrial, endurance, and strength outcomesFatigue reduction and contexts involving CoQ10 statusEvidence is outcome-specific
Direct mitochondrial actionHelps remove damaged mitochondriaSupports ATP production inside existing mitochondriaDifferent layers of mitochondrial function
Human evidenceSeveral randomized trials and a recent systematic reviewMany trials across diverse healthy and clinical populationsCoQ10 evidence is broader but heterogeneous
Typical studied intake500–1,000 mg dailyDose and formulation vary widely by study and indicationFormulation and context matter
Most relevant goalMitochondrial quality, muscle endurance, healthy agingFatigue, antioxidant support, or identified CoQ10 needsGoal determines fit

Mechanisms

How the biology differs.

Urolithin A

Targets mitochondrial quality

Urolithin A activates mitophagy, the selective recycling process that removes damaged mitochondria. Its human evidence is newer and more focused than the broad CoQ10 literature.

CoQ10

Supports energy transfer

CoQ10 transfers electrons within the mitochondrial respiratory chain, helping drive ATP production. It also acts as an antioxidant in membranes and lipoproteins.

Human evidence

What the studies show—and what they do not.

Urolithin A evidence

Randomized muscle studies with precise limits

Trials reported improvements in selected strength or endurance measures and favorable biomarkers. Several primary functional endpoints did not significantly improve, and larger, longer studies are needed.

CoQ10 evidence

Fatigue benefits across pooled trials

A 2022 meta-analysis of 13 randomized trials involving 1,126 participants found a significant reduction in fatigue scores. Exercise-performance findings remain inconsistent and population dependent.

Choosing by goal

Start with the outcome, not the ingredient.

Choose CoQ10 when the priority is:

  • Addressing fatigue with an ingredient supported by pooled trials
  • Supporting mitochondrial electron transport and antioxidant activity
  • Discussing medication-related or clinical CoQ10 needs with a clinician
  • A broad, though heterogeneous, research history

Consider Urolithin A when the priority is:

  • Mitochondrial quality control through mitophagy
  • Muscle endurance and healthy-aging goals
  • A clinically studied postbiotic with selected human muscle outcomes
  • A consistent dose independent of microbiome conversion

Where Mitopure fits.

Mitopure® is Amazentis’ proprietary, highly pure form of Urolithin A used in published human clinical studies. CoQ10 supports electron transfer and antioxidant function in existing mitochondria; Mitopure targets the quality-control process that identifies and recycles damaged mitochondria.

References

The evidence behind this comparison.

Common questions

Urolithin A and CoQ10.

A hand preparing a measured dose of Mitopure

Bring the science home with Timeline.

Explore Mitopure
#1

Clinically studied

Urolithin A

The Swiss life-science company pioneering Urolithin A, advancing the science of cellular longevity since 2007.

Contact

EPFL Innovation Park, Bâtiment C
1015 Lausanne, Switzerland
contact@amazentis.com

* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

References: Our clinical study showed that sedentary, middle-aged adults with an average BMI of 29.52 increased hamstring muscle strength. Nutrition NOURISH Study: 500mg Mitopure® have been shown to deliver at least 6 times higher Urolithin A plasma levels over 24 hours (area under the curve) than 8 ounces (240ml) of pomegranate juice in a randomized human clinical trial.